GS MZ1 12.5 (Promacta 12.5 mg)
Generic Name: eltrombopag
This pill with imprint "GS MZ1 12.5" is White, Round and has been identified as Promacta 12.5 mg. It is manufactured by GlaxoSmithKline.
Promacta is used in the treatment of aplastic anemia; idiopathic thrombocytopenic purpura; thrombocytopenia idiopathic; thrombocytopenia and belongs to the drug class platelet-stimulating agents. Risk cannot be ruled out during pregnancy. Promacta 12.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- eltrombopag
- Imprint:
- GS MZ1 12.5
- Strength:
- 12.5 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Platelet-stimulating agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- GlaxoSmithKline
More about Promacta (eltrombopag)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: platelet-stimulating agents
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
